Specifically, we proposed that if fees paid by a manufacturer to an entity vary directly with the amount or price of a manufacturer's drugs (that is, the fees paid are (1) percentage-based fees or (2) flat fees or fixed fees that are designed in such a way as to approximate percentage-based fees), such fees are presumed to be price concessions to be deducted from the calculation of the manufacturer's ASP unless such manufacturer determines such fees to be FMV using a cost-based approach which may be further validated with market-based data
In: Axelrod J, Fraschini, F., Velo, G.P
We always recommend consulting with your healthcare provider before starting any new treatment, including vitamin injections, to ensure it is safe and tailored to your individual health needs
Injection site considerations for different disc levels Where you inject BPC-157 matters because of its primarily local action
Key citation: Bhatt DL et al., Washington State University preclinical models demonstrating Dihexas HGF/c-Met-mediated synaptogenic activity
Collectively, these peptides accelerate repair processes, reduce inflammation, and enhance tissue regeneration at cellular and molecular levels